42 U.S.C. § 244b — Activities relating to cardiomyopathy

Page 169 TITLE 42—THE PUBLIC HEALTH AND WELFARE § 244b (3) training information on automated exter- nal defibrillators and cardiopulmonary resus- citation; and (4) recommendations for how schools, early childhood education programs, and child care centers can develop and implement a cardiac emergency response plan. (b) Dissemination of materials and resources Not later than 30 months after December 23, 2024, the Secretary shall disseminate the mate- rials and resources developed under subsection (a) in accordance with the following: (1) Distribution by State educational agencies The Secretary shall make available such materials and resources to State educational agencies to distribute— (A) to school administrators, educators, school health professionals, coaches, fami- lies, guardians, caregivers, and other appro- priate individuals, the information devel- oped under subsection (a)(1); (B) to parents, guardians, or other care- givers, the cardiomyopathy risk assessment developed pursuant to section 244b(b)(1) of this title; and (C) to school administrators, educators, school health professionals, and coaches— (i) the guidelines described in subsection (a)(2); (ii) the training information described in subsection (a)(3); and (iii) the recommendations described in subsection (a)(4). (2) Dissemination to health departments and professionals The Secretary shall make available the ma- terials and resources developed under sub- section (a) to State and local health depart- ments, pediatricians, hospitals, and other health professionals, such as nurses and first responders. (3) Posting on website (A) CDC (i) In general The Secretary, through the Director, shall post the materials and resources de- veloped under subsection (a) on the public Internet website of the Centers for Disease Control and Prevention. (ii) Additional information The Director is encouraged to maintain on such public Internet website such addi- tional information regarding cardio- myopathy as deemed appropriate by the Director. (B) State educational agencies State educational agencies are encouraged to create public Internet webpages dedicated to cardiomyopathy and post the materials and resources developed under subsection (a) on such webpages. (c) Definitions In this section: (1) The term ‘‘cardiomyopathy’’ means a heart disease that affects the heart’s muscle (myocardium)— (A) the symptoms of which may vary from case to case, including— (i) cases in which no symptoms are present (asymptomatic); and (ii) cases in which there are symptoms of a progressive condition that may result from an impaired ability of the heart to pump blood, such as fatigue, irregular heartbeats (arrhythmia), heart failure, and, potentially, sudden cardiac death; and (B) the recognized types of which include dilated, hypertrophic, restrictive, arrhythmogenic right ventricular dysplasia, and left ventricular non-compaction. (2) The term ‘‘Director’’ means the Director of the Centers for Disease Control and Preven- tion. (3) The terms ‘‘early childhood education program’’, ‘‘elementary school’’, and ‘‘sec- ondary school’’ have the meanings given to those terms in section 7801 of title 20. (4) The term ‘‘school administrator’’ means a principal, director, manager, or other super- visor or leader within an elementary school, secondary school, State-based early childhood education program, or child care center. (5) The term ‘‘school health professional’’ means a health professional serving at an ele- mentary school, secondary school, State-based early childhood education program, or child care center. (July 1, 1944, ch. 373, title III, § 312A, as added Pub. L. 118–176, § 2(a), Dec. 23, 2024, 138 Stat. 2605.) Editorial Notes PRIOR PROVISIONS A prior section 244a, act July 1, 1944, ch. 373, title III, § 312a, as added Aug. 31, 1954, ch. 1158, § 2, 68 Stat. 1025, related to birth and death statistics, annual collection, and compensation for transcription, prior to repeal by Pub. L. 93–353, title I, § 102(a), July 23, 1974, 88 Stat. 362. See section 242k(h)(1) of this title. § 244b. Activities relating to cardiomyopathy (a) Report on CDC national cardiomyopathy ac- tivities (1) In general Not later than 18 months after December 23, 2024, the Secretary, acting through the Direc- tor of the Centers for Disease Control and Pre- vention, shall submit to Congress a report on findings generated from existing activities conducted by the Centers for Disease Control and Prevention to improve the understanding of the prevalence and epidemiology of cardio- myopathy across the lifespan, from birth to adulthood, with particular interest in the fol- lowing: (A) The natural history of individuals with cardiomyopathy, in both the pediatric and adult population. (B) Estimates of cardiomyopathy-related emergency department visits and hos- pitalizations, in both the pediatric and adult population. (2) Public access Subject to paragraph (3), the report sub- mitted under this subsection shall be made available to the public. Page 170 TITLE 42—THE PUBLIC HEALTH AND WELFARE § 244c (3) Privacy protections The Secretary shall ensure that this sub- section is carried out in a manner that com- plies with all applicable privacy laws under Federal and State law. (b) Improving risk assessments for individuals with cardiomyopathy (1) In general The Secretary shall develop and make pub- licly available a cardiomyopathy risk assess- ment for health care providers and individ- uals. Such risk assessment shall, at a min- imum, include the following: (A) Background information on the preva- lence, incidence, and health impact of car- diomyopathy, including all forms of cardio- myopathy and their effects on pediatric, ad- olescent, and adult individuals. (B) A worksheet with variables and condi- tions for an individual or health care pro- vider to use in assessing whether an indi- vidual is at risk for cardiomyopathy. (C) A worksheet with variables and stages of progression for an individual or health care provider to use in assessing whether and to what extent cardiomyopathy has pro- gressed in an individual. (D) Guidelines on cardiomyopathy screenings for individuals who are at risk for, or have a family history of, cardio- myopathy. (2) Stakeholder input In carrying out paragraph (1), the Director of the Centers for Disease Control and Preven- tion shall seek input from external stake- holders including— (A) representatives from national patient advocacy organizations expert in all forms of cardiomyopathy; (B) representatives from medical profes- sional societies that specialize in the care of adults and pediatrics with cardiomyopathy; and (C) representatives from other relevant Federal agencies. (c) Definition In this section, the term ‘‘cardiomyopathy’’ has the meaning given to such term in section 244a of this title. (July 1, 1944, ch. 373, title III, § 312B, as added Pub. L. 118–176, § 2(a), Dec. 23, 2024, 138 Stat. 2607.) § 244c. Cardiomyopathy research (a) In general The Secretary, in consultation with the Direc- tor of the National Institutes of Health, may ex- pand and coordinate research and related activi- ties of the National Institutes of Health with re- spect to cardiomyopathy, which may include re- search with respect to— (1) causation of cardiomyopathy, including genetic causes and molecular biomarkers; (2) long-term health outcomes in individuals with cardiomyopathy, including infants, chil- dren, teenagers, adults, and elderly individ- uals; and (3) studies using longitudinal data and retro- spective analysis to identify effective treat- ments and outcomes for individuals with car- diomyopathy. (b) Nonduplication The Secretary shall ensure that any research and activities related to cardiomyopathy under this section do not unnecessarily duplicate ac- tivities, programs, or efforts of other agencies and offices within the Department of Health and Human Services. (c) NIH report Not later than 18 months after December 23, 2024, the Secretary, in consultation with the Di- rector of the National Institutes of Health, shall submit to Congress a report— (1) outlining the ongoing research efforts of the National Institutes of Health regarding cardiomyopathy; and (2) identifying— (A) a research agenda regarding adult forms of cardiomyopathy; (B) plans for researching cardiomyopathy affecting the pediatric population; and (C) the areas of greatest need for such re- search. (d) Cardiomyopathy defined In this section, the term ‘‘cardiomyopathy’’ has the meaning given to such term in section 244a of this title. (July 1, 1944, ch. 373, title III, § 312C, as added Pub. L. 118–176, § 2(a), Dec. 23, 2024, 138 Stat. 2608.) § 244d. Promoting student access to AEDs and CPR (a) In general The Secretary may award grants to eligible entities to develop and implement a comprehen- sive program to promote student access to auto- mated external defibrillators (in this section re- ferred to as ‘‘AEDs’’) and cardiopulmonary re- suscitation (in this section referred to as ‘‘CPR’’) in public elementary schools and sec- ondary schools. (b) Use of funds An eligible entity receiving a grant under sub- section (a) may use funds received through such grant to carry out any of the following activi- ties: (1) Developing and providing comprehensive materials to establish AED and CPR programs in public elementary schools and secondary schools. (2) Providing support for CPR and AED training programs in such schools for stu- dents, staff, and related sports volunteers. (3) Providing support for developing a car- diac emergency response plan within such schools. (4) Purchasing AEDs that have been ap- proved under section 360e of title 21, cleared under section 360(k) of such title, or classified under section 360c(f)(2) of such title. (5) Purchasing necessary AED batteries and performing necessary AED maintenance (such as by replacing AED pads) in accordance with the labeling of the AED involved.